Mario Valenzano Menada
Overview
Explore the profile of Mario Valenzano Menada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sala P, Bogliolo S, Barra F, Fazio A, Maramai M, Cassani C, et al.
J Invest Surg
. 2020 Dec;
35(2):308-314.
PMID: 33289585
Objectives: This study aims to evaluate oncological outcomes in women affected by locally advanced cervical cancer (LACC) treated by neoadjuvant chemotherapy before radical surgery (NACT + RS) or concurrent chemo-radiotherapy...
2.
Maramai M, Barra F, Valenzano Menada M, Stigliani S, Moioli M, Costantini S, et al.
Ecancermedicalscience
. 2020 May;
14:1031.
PMID: 32419843
Borderline ovarian tumours (BOTs) are ovarian neoplasms characterised by epithelial proliferation, variable nuclear atypia and no evidence of destructive stromal invasion. BOTs account for approximately 15% of all epithelial ovarian...
3.
Moioli M, Barra F, Maramai M, Valenzano Menada M, Vellone V, Costantini S, et al.
Expert Opin Investig Drugs
. 2019 Nov;
28(12):1025-1029.
PMID: 31726889
No abstract available.
4.
Bizzarri N, Vellone V, Parodi L, Calanni Fraccono L, Ghirardi V, Costantini S, et al.
J Obstet Gynaecol
. 2017 Jun;
37(8):975-981.
PMID: 28657384
Vulvar cancer accounts for 5% of the female genital tract cancers. Cutaneous metastases from vulvar cancer are extremely rare and for this reason, it can be difficult to reach a...
5.
Lambertini M, Cinquini M, Moschetti I, Peccatori F, Anserini P, Valenzano Menada M, et al.
Eur J Cancer
. 2016 Dec;
71:25-33.
PMID: 27940355
The development of premature ovarian failure and subsequent infertility are possible consequences of chemotherapy use in pre-menopausal women with early-stage breast cancer. Among the available strategies for fertility preservation, pharmacological...
6.
Sala P, Moran E, Paolucci R, Menoni S, Fulcheri E, Costantini S, et al.
Minerva Ginecol
. 2016 Mar;
68(1):21-8.
PMID: 26990099
Background: The aim of this paper was to assess the accuracy of frozen sections histological examination and preoperative CA-125 to select patients with high risk endometrial cancer. Methods: We reviewed...
7.
Bizzarri N, Ghirardi V, Alessandri F, Venturini P, Valenzano Menada M, Rundle S, et al.
Expert Opin Biol Ther
. 2016 Jan;
16(3):407-19.
PMID: 26796332
Introduction: Cervical cancer is still a major cause of morbidity and mortality in women. Early stages and locally advanced cervical cancer are currently treated respectively with surgery and chemoradiation with...
8.
Sala P, Morotti M, Valenzano Menada M, Cannavino E, Maffeo I, Abete L, et al.
Int J Gynecol Cancer
. 2014 Jun;
24(6):1021-6.
PMID: 24905611
Objective: The aim of this study was to investigate the frozen section (FS) accuracy in tailoring the surgical staging of patients affected by endometrial cancer, using 2 different risk classifications....
9.
Leone Roberti Maggiore U, Valenzano Menada M, Venturini P, Ferrero S
Expert Opin Investig Drugs
. 2013 Sep;
22(12):1671-86.
PMID: 24070205
Introduction: Sunitinib malate (SU11248; Sutent®; Pfizer, Inc., New York) is a multi-kinase inhibitor currently approved for use in advanced renal cell carcinoma (RCC), imatinib-resistant/-intolerant gastrointestinal stromal tumours and progressive, well-differentiated...
10.
Morotti M, Becker C, Valenzano Menada M, Ferrero S
Expert Opin Investig Drugs
. 2013 Jul;
22(10):1265-79.
PMID: 23815710
Introduction: Epithelial ovarian cancer (EOC) is the leading cause of gynaecologic cancer death. Although in some cases initial treatment is effective, most of the women diagnosed with EOC will probably...